Global Antisense Oligonucleotides Market Size, Status and Forecast 2024-2031

Report ID: 922972 | Published Date: Sep 2024 | No. of Page: 123 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antisense Oligonucleotides Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 RNA Antisense Oligonucleotides
        1.2.3 DNA Antisense Oligonucleotides
    1.3 Market by Application
        1.3.1 Global Antisense Oligonucleotides Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Antisense Oligonucleotides Market Perspective (2016-2027)
    2.2 Antisense Oligonucleotides Growth Trends by Regions
        2.2.1 Antisense Oligonucleotides Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Antisense Oligonucleotides Historic Market Share by Regions (2016-2021)
        2.2.3 Antisense Oligonucleotides Forecasted Market Size by Regions (2022-2027)
    2.3 Antisense Oligonucleotides Industry Dynamic
        2.3.1 Antisense Oligonucleotides Market Trends
        2.3.2 Antisense Oligonucleotides Market Drivers
        2.3.3 Antisense Oligonucleotides Market Challenges
        2.3.4 Antisense Oligonucleotides Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Antisense Oligonucleotides Players by Revenue
        3.1.1 Global Top Antisense Oligonucleotides Players by Revenue (2016-2021)
        3.1.2 Global Antisense Oligonucleotides Revenue Market Share by Players (2016-2021)
    3.2 Global Antisense Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Antisense Oligonucleotides Revenue
    3.4 Global Antisense Oligonucleotides Market Concentration Ratio
        3.4.1 Global Antisense Oligonucleotides Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotides Revenue in 2020
    3.5 Antisense Oligonucleotides Key Players Head office and Area Served
    3.6 Key Players Antisense Oligonucleotides Product Solution and Service
    3.7 Date of Enter into Antisense Oligonucleotides Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Antisense Oligonucleotides Breakdown Data by Type
    4.1 Global Antisense Oligonucleotides Historic Market Size by Type (2016-2021)
    4.2 Global Antisense Oligonucleotides Forecasted Market Size by Type (2022-2027)

5 Antisense Oligonucleotides Breakdown Data by Application
    5.1 Global Antisense Oligonucleotides Historic Market Size by Application (2016-2021)
    5.2 Global Antisense Oligonucleotides Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Antisense Oligonucleotides Market Size (2016-2027)
    6.2 North America Antisense Oligonucleotides Market Size by Type
        6.2.1 North America Antisense Oligonucleotides Market Size by Type (2016-2021)
        6.2.2 North America Antisense Oligonucleotides Market Size by Type (2022-2027)
        6.2.3 North America Antisense Oligonucleotides Market Size by Type (2016-2027)
    6.3 North America Antisense Oligonucleotides Market Size by Application
        6.3.1 North America Antisense Oligonucleotides Market Size by Application (2016-2021)
        6.3.2 North America Antisense Oligonucleotides Market Size by Application (2022-2027)
        6.3.3 North America Antisense Oligonucleotides Market Size by Application (2016-2027)
    6.4 North America Antisense Oligonucleotides Market Size by Country
        6.4.1 North America Antisense Oligonucleotides Market Size by Country (2016-2021)
        6.4.2 North America Antisense Oligonucleotides Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Antisense Oligonucleotides Market Size (2016-2027)
    7.2 Europe Antisense Oligonucleotides Market Size by Type
        7.2.1 Europe Antisense Oligonucleotides Market Size by Type (2016-2021)
        7.2.2 Europe Antisense Oligonucleotides Market Size by Type (2022-2027)
        7.2.3 Europe Antisense Oligonucleotides Market Size by Type (2016-2027)
    7.3 Europe Antisense Oligonucleotides Market Size by Application
        7.3.1 Europe Antisense Oligonucleotides Market Size by Application (2016-2021)
        7.3.2 Europe Antisense Oligonucleotides Market Size by Application (2022-2027)
        7.3.3 Europe Antisense Oligonucleotides Market Size by Application (2016-2027)
    7.4 Europe Antisense Oligonucleotides Market Size by Country
        7.4.1 Europe Antisense Oligonucleotides Market Size by Country (2016-2021)
        7.4.2 Europe Antisense Oligonucleotides Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Antisense Oligonucleotides Market Size (2016-2027)
    8.2 Asia-Pacific Antisense Oligonucleotides Market Size by Type
        8.2.1 Asia-Pacific Antisense Oligonucleotides Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Antisense Oligonucleotides Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Antisense Oligonucleotides Market Size by Type (2016-2027)
    8.3 Asia-Pacific Antisense Oligonucleotides Market Size by Application
        8.3.1 Asia-Pacific Antisense Oligonucleotides Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Antisense Oligonucleotides Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Antisense Oligonucleotides Market Size by Application (2016-2027)
    8.4 Asia-Pacific Antisense Oligonucleotides Market Size by Region
        8.4.1 Asia-Pacific Antisense Oligonucleotides Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Antisense Oligonucleotides Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Antisense Oligonucleotides Market Size (2016-2027)
    9.2 Latin America Antisense Oligonucleotides Market Size by Type
        9.2.1 Latin America Antisense Oligonucleotides Market Size by Type (2016-2021)
        9.2.2 Latin America Antisense Oligonucleotides Market Size by Type (2022-2027)
        9.2.3 Latin America Antisense Oligonucleotides Market Size by Type (2016-2027)
    9.3 Latin America Antisense Oligonucleotides Market Size by Application
        9.3.1 Latin America Antisense Oligonucleotides Market Size by Application (2016-2021)
        9.3.2 Latin America Antisense Oligonucleotides Market Size by Application (2022-2027)
        9.3.3 Latin America Antisense Oligonucleotides Market Size by Application (2016-2027)
    9.4 Latin America Antisense Oligonucleotides Market Size by Country
        9.4.1 Latin America Antisense Oligonucleotides Market Size by Country (2016-2021)
        9.4.2 Latin America Antisense Oligonucleotides Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Antisense Oligonucleotides Market Size (2016-2027)
    10.2 Middle East & Africa Antisense Oligonucleotides Market Size by Type
        10.2.1 Middle East & Africa Antisense Oligonucleotides Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Antisense Oligonucleotides Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Antisense Oligonucleotides Market Size by Type (2016-2027)
    10.3 Middle East & Africa Antisense Oligonucleotides Market Size by Application
        10.3.1 Middle East & Africa Antisense Oligonucleotides Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Antisense Oligonucleotides Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Antisense Oligonucleotides Market Size by Application (2016-2027)
    10.4 Middle East & Africa Antisense Oligonucleotides Market Size by Country
        10.4.1 Middle East & Africa Antisense Oligonucleotides Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Antisense Oligonucleotides Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Ionis Pharmaceuticals
        11.1.1 Ionis Pharmaceuticals Company Details
        11.1.2 Ionis Pharmaceuticals Business Overview
        11.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides Introduction
        11.1.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.1.5 Ionis Pharmaceuticals Recent Development
    11.2 Sarepta Therapeutics
        11.2.1 Sarepta Therapeutics Company Details
        11.2.2 Sarepta Therapeutics Business Overview
        11.2.3 Sarepta Therapeutics Antisense Oligonucleotides Introduction
        11.2.4 Sarepta Therapeutics Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.2.5 Sarepta Therapeutics Recent Development
    11.3 Biogen
        11.3.1 Biogen Company Details
        11.3.2 Biogen Business Overview
        11.3.3 Biogen Antisense Oligonucleotides Introduction
        11.3.4 Biogen Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.3.5 Biogen Recent Development
    11.4 Alnylam Pharmaceuticals
        11.4.1 Alnylam Pharmaceuticals Company Details
        11.4.2 Alnylam Pharmaceuticals Business Overview
        11.4.3 Alnylam Pharmaceuticals Antisense Oligonucleotides Introduction
        11.4.4 Alnylam Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.4.5 Alnylam Pharmaceuticals Recent Development
    11.5 Antisense Therapeutics
        11.5.1 Antisense Therapeutics Company Details
        11.5.2 Antisense Therapeutics Business Overview
        11.5.3 Antisense Therapeutics Antisense Oligonucleotides Introduction
        11.5.4 Antisense Therapeutics Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.5.5 Antisense Therapeutics Recent Development
    11.6 Isarna Therapeutics
        11.6.1 Isarna Therapeutics Company Details
        11.6.2 Isarna Therapeutics Business Overview
        11.6.3 Isarna Therapeutics Antisense Oligonucleotides Introduction
        11.6.4 Isarna Therapeutics Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.6.5 Isarna Therapeutics Recent Development
    11.7 Arrowhead Pharmaceuticals
        11.7.1 Arrowhead Pharmaceuticals Company Details
        11.7.2 Arrowhead Pharmaceuticals Business Overview
        11.7.3 Arrowhead Pharmaceuticals Antisense Oligonucleotides Introduction
        11.7.4 Arrowhead Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.7.5 Arrowhead Pharmaceuticals Recent Development
    11.8 Atlantic Pharmaceuticals
        11.8.1 Atlantic Pharmaceuticals Company Details
        11.8.2 Atlantic Pharmaceuticals Business Overview
        11.8.3 Atlantic Pharmaceuticals Antisense Oligonucleotides Introduction
        11.8.4 Atlantic Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.8.5 Atlantic Pharmaceuticals Recent Development
    11.9 Enzon Pharmaceuticals
        11.9.1 Enzon Pharmaceuticals Company Details
        11.9.2 Enzon Pharmaceuticals Business Overview
        11.9.3 Enzon Pharmaceuticals Antisense Oligonucleotides Introduction
        11.9.4 Enzon Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.9.5 Enzon Pharmaceuticals Recent Development
    11.10 Bio-Path Holdings
        11.10.1 Bio-Path Holdings Company Details
        11.10.2 Bio-Path Holdings Business Overview
        11.10.3 Bio-Path Holdings Antisense Oligonucleotides Introduction
        11.10.4 Bio-Path Holdings Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.10.5 Bio-Path Holdings Recent Development
    11.11 GlaxoSmithKline
        11.11.1 GlaxoSmithKline Company Details
        11.11.2 GlaxoSmithKline Business Overview
        11.11.3 GlaxoSmithKline Antisense Oligonucleotides Introduction
        11.11.4 GlaxoSmithKline Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.11.5 GlaxoSmithKline Recent Development
    11.12 Geron
        11.12.1 Geron Company Details
        11.12.2 Geron Business Overview
        11.12.3 Geron Antisense Oligonucleotides Introduction
        11.12.4 Geron Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.12.5 Geron Recent Development
    11.13 ICO Therapeutics
        11.13.1 ICO Therapeutics Company Details
        11.13.2 ICO Therapeutics Business Overview
        11.13.3 ICO Therapeutics Antisense Oligonucleotides Introduction
        11.13.4 ICO Therapeutics Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.13.5 ICO Therapeutics Recent Development
    11.14 Marina Biotech
        11.14.1 Marina Biotech Company Details
        11.14.2 Marina Biotech Business Overview
        11.14.3 Marina Biotech Antisense Oligonucleotides Introduction
        11.14.4 Marina Biotech Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.14.5 Marina Biotech Recent Development
    11.15 RXi Pharmaceuticals
        11.15.1 RXi Pharmaceuticals Company Details
        11.15.2 RXi Pharmaceuticals Business Overview
        11.15.3 RXi Pharmaceuticals Antisense Oligonucleotides Introduction
        11.15.4 RXi Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021)
        11.15.5 RXi Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Antisense Oligonucleotides Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of RNA Antisense Oligonucleotides
    Table 3. Key Players of DNA Antisense Oligonucleotides
    Table 4. Global Antisense Oligonucleotides Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Antisense Oligonucleotides Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Antisense Oligonucleotides Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Antisense Oligonucleotides Market Share by Regions (2016-2021)
    Table 8. Global Antisense Oligonucleotides Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Antisense Oligonucleotides Market Share by Regions (2022-2027)
    Table 10. Antisense Oligonucleotides Market Trends
    Table 11. Antisense Oligonucleotides Market Drivers
    Table 12. Antisense Oligonucleotides Market Challenges
    Table 13. Antisense Oligonucleotides Market Restraints
    Table 14. Global Antisense Oligonucleotides Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Antisense Oligonucleotides Market Share by Players (2016-2021)
    Table 16. Global Top Antisense Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antisense Oligonucleotides as of 2020)
    Table 17. Ranking of Global Top Antisense Oligonucleotides Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Antisense Oligonucleotides Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Antisense Oligonucleotides Product Solution and Service
    Table 21. Date of Enter into Antisense Oligonucleotides Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Antisense Oligonucleotides Revenue Market Share by Type (2016-2021)
    Table 25. Global Antisense Oligonucleotides Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Antisense Oligonucleotides Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Antisense Oligonucleotides Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Antisense Oligonucleotides Revenue Market Share by Application (2016-2021)
    Table 29. Global Antisense Oligonucleotides Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Antisense Oligonucleotides Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Antisense Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Antisense Oligonucleotides Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Antisense Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Antisense Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Antisense Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Antisense Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Antisense Oligonucleotides Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Antisense Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Antisense Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Antisense Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Antisense Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Antisense Oligonucleotides Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Antisense Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Antisense Oligonucleotides Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Antisense Oligonucleotides Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Antisense Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Antisense Oligonucleotides Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Antisense Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Antisense Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Antisense Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Antisense Oligonucleotides Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Antisense Oligonucleotides Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Antisense Oligonucleotides Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Antisense Oligonucleotides Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Antisense Oligonucleotides Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Antisense Oligonucleotides Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Ionis Pharmaceuticals Company Details
    Table 62. Ionis Pharmaceuticals Business Overview
    Table 63. Ionis Pharmaceuticals Antisense Oligonucleotides Product
    Table 64. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 65. Ionis Pharmaceuticals Recent Development
    Table 66. Sarepta Therapeutics Company Details
    Table 67. Sarepta Therapeutics Business Overview
    Table 68. Sarepta Therapeutics Antisense Oligonucleotides Product
    Table 69. Sarepta Therapeutics Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 70. Sarepta Therapeutics Recent Development
    Table 71. Biogen Company Details
    Table 72. Biogen Business Overview
    Table 73. Biogen Antisense Oligonucleotides Product
    Table 74. Biogen Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 75. Biogen Recent Development
    Table 76. Alnylam Pharmaceuticals Company Details
    Table 77. Alnylam Pharmaceuticals Business Overview
    Table 78. Alnylam Pharmaceuticals Antisense Oligonucleotides Product
    Table 79. Alnylam Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 80. Alnylam Pharmaceuticals Recent Development
    Table 81. Antisense Therapeutics Company Details
    Table 82. Antisense Therapeutics Business Overview
    Table 83. Antisense Therapeutics Antisense Oligonucleotides Product
    Table 84. Antisense Therapeutics Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 85. Antisense Therapeutics Recent Development
    Table 86. Isarna Therapeutics Company Details
    Table 87. Isarna Therapeutics Business Overview
    Table 88. Isarna Therapeutics Antisense Oligonucleotides Product
    Table 89. Isarna Therapeutics Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 90. Isarna Therapeutics Recent Development
    Table 91. Arrowhead Pharmaceuticals Company Details
    Table 92. Arrowhead Pharmaceuticals Business Overview
    Table 93. Arrowhead Pharmaceuticals Antisense Oligonucleotides Product
    Table 94. Arrowhead Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 95. Arrowhead Pharmaceuticals Recent Development
    Table 96. Atlantic Pharmaceuticals Company Details
    Table 97. Atlantic Pharmaceuticals Business Overview
    Table 98. Atlantic Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 99. Atlantic Pharmaceuticals Recent Development
    Table 100. Enzon Pharmaceuticals Company Details
    Table 101. Enzon Pharmaceuticals Business Overview
    Table 102. Enzon Pharmaceuticals Antisense Oligonucleotides Product
    Table 103. Enzon Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 104. Enzon Pharmaceuticals Recent Development
    Table 105. Bio-Path Holdings Company Details
    Table 106. Bio-Path Holdings Business Overview
    Table 107. Bio-Path Holdings Antisense Oligonucleotides Product
    Table 108. Bio-Path Holdings Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 109. Bio-Path Holdings Recent Development
    Table 110. GlaxoSmithKline Company Details
    Table 111. GlaxoSmithKline Business Overview
    Table 112. GlaxoSmithKline Antisense Oligonucleotides Product
    Table 113. GlaxoSmithKline Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 114. GlaxoSmithKline Recent Development
    Table 115. Geron Company Details
    Table 116. Geron Business Overview
    Table 117. Geron Antisense Oligonucleotides Product
    Table 118. Geron Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 119. Geron Recent Development
    Table 120. ICO Therapeutics Company Details
    Table 121. ICO Therapeutics Business Overview
    Table 122. ICO Therapeutics Antisense Oligonucleotides Product
    Table 123. ICO Therapeutics Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 124. ICO Therapeutics Recent Development
    Table 125. Marina Biotech Company Details
    Table 126. Marina Biotech Business Overview
    Table 127. Marina Biotech Antisense Oligonucleotides Product
    Table 128. Marina Biotech Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 129. Marina Biotech Recent Development
    Table 130. RXi Pharmaceuticals Company Details
    Table 131. RXi Pharmaceuticals Business Overview
    Table 132. RXi Pharmaceuticals Antisense Oligonucleotides Product
    Table 133. RXi Pharmaceuticals Revenue in Antisense Oligonucleotides Business (2016-2021) & (US$ Million)
    Table 134. RXi Pharmaceuticals Recent Development
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antisense Oligonucleotides Market Share by Type: 2020 VS 2027
    Figure 2. RNA Antisense Oligonucleotides Features
    Figure 3. DNA Antisense Oligonucleotides Features
    Figure 4. Global Antisense Oligonucleotides Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Others Case Studies
    Figure 8. Antisense Oligonucleotides Report Years Considered
    Figure 9. Global Antisense Oligonucleotides Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Antisense Oligonucleotides Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Antisense Oligonucleotides Market Share by Regions: 2020 VS 2027
    Figure 12. Global Antisense Oligonucleotides Market Share by Regions (2022-2027)
    Figure 13. Global Antisense Oligonucleotides Market Share by Players in 2020
    Figure 14. Global Top Antisense Oligonucleotides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antisense Oligonucleotides as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Antisense Oligonucleotides Revenue in 2020
    Figure 16. Global Antisense Oligonucleotides Revenue Market Share by Type (2016-2021)
    Figure 17. Global Antisense Oligonucleotides Revenue Market Share by Type (2022-2027)
    Figure 18. North America Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Antisense Oligonucleotides Market Share by Type (2016-2027)
    Figure 20. North America Antisense Oligonucleotides Market Share by Application (2016-2027)
    Figure 21. North America Antisense Oligonucleotides Market Share by Country (2016-2027)
    Figure 22. United States Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Antisense Oligonucleotides Market Share by Type (2016-2027)
    Figure 26. Europe Antisense Oligonucleotides Market Share by Application (2016-2027)
    Figure 27. Europe Antisense Oligonucleotides Market Share by Country (2016-2027)
    Figure 28. Germany Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Antisense Oligonucleotides Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Antisense Oligonucleotides Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Antisense Oligonucleotides Market Share by Region (2016-2027)
    Figure 38. China Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Antisense Oligonucleotides Market Share by Type (2016-2027)
    Figure 46. Latin America Antisense Oligonucleotides Market Share by Application (2016-2027)
    Figure 47. Latin America Antisense Oligonucleotides Market Share by Country (2016-2027)
    Figure 48. Mexico Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Antisense Oligonucleotides Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Antisense Oligonucleotides Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Antisense Oligonucleotides Market Share by Country (2016-2027)
    Figure 54. Turkey Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Antisense Oligonucleotides Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 58. Sarepta Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 59. Biogen Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 60. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 61. Antisense Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 62. Isarna Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 63. Arrowhead Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 64. Atlantic Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 65. Enzon Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 66. Bio-Path Holdings Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 67. GlaxoSmithKline Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 68. Geron Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 69. ICO Therapeutics Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 70. Marina Biotech Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 71. RXi Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotides Business (2016-2021)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ionis Pharmaceuticals
Sarepta Therapeutics
Biogen
Alnylam Pharmaceuticals
Antisense Therapeutics
Isarna Therapeutics
Arrowhead Pharmaceuticals
Atlantic Pharmaceuticals
Enzon Pharmaceuticals
Bio-Path Holdings
GlaxoSmithKline
Geron
ICO Therapeutics
Marina Biotech
RXi Pharmaceuticals
Frequently Asked Questions
Antisense Oligonucleotides report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antisense Oligonucleotides report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antisense Oligonucleotides report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Mono Rapid Testing

Mono rapid testing is a type of point of care testing for the qualitative detection of mononucleo ... Read More